Back

Aortic valve intervention in patients with liver cirrhosis; TAVI is a viable option

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Aortic valve disease Surgery and intervention in valve disease ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Omar Aldalati

King's College Hospital, London (United Kingdom of Great Britain & Northern Ireland)

26 More presentations in this session

Presentation thumbnail
Anatomical and procedural predictors for permanent pacemaker after newer generation balloon-expandable transcatheter aortic valve implantation
Doctor Y. Maeno (Tokyo, JP)
Presentation thumbnail
Significant aortic regurgitation as a result of the interaction of self-, balloon- and mechanically expanded transcatheter heart valves with aortic root.
Doctor R. Rodriguez Olivares (Seville, ES)
Abstract Slides
Presentation thumbnail
Is aortic stenosis associated with anaemia: review of 1084 patients at a tertiary cardiac centre.
Doctor F. Choudhary (Nottingham, GB)
Abstract
Presentation thumbnail
MicroRNA expression profiles of throracic aortic aneurysms in bicuspid aortic valve by next-generation sequencing
Doctor I. Foffa
Abstract
Presentation thumbnail
Importance of aortic valve short axis measurements for prediction of aortic regurgitation caused by aortic root dilatation
Assistant Professor A. Tsuneto (Nagasaki, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Aortic valve disease

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources